NNT
NAD(P) transhydrogenase, mitochondrial
Also known as: NNTM_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13423
- Gene
- NNT
- Ensembl
- ENSG00000112992
- Chromosome
- 5
- Canonical length
- 1086 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes an integral protein of the inner mitochondrial membrane. The enzyme couples hydride transfer between NAD(H) and NADP(+) to proton translocation across the inner mitochondrial membrane. Under most physiological conditions, the enzyme uses energy from the mitochondrial proton gradient to produce high concentrations of NADPH. The resulting NADPH is used for biosynthesis and in free radical detoxification. [provided by RefSeq, Sep 2016]
Canonical amino-acid sequenceUniProt
1086 residues, UniProt reviewed canonical sequence.
>Q13423|NNT
1 MANLLKTVVT GCSCPLLSNL GSCKGLRVKK DFLRTFYTHQ ELWCKAPVKP GIPYKQLTVG
61 VPKEIFQNEK RVALSPAGVQ NLVKQGFNVV VESGAGEASK FSDDHYRVAG AQIQGAKEVL
121 ASDLVVKVRA PMVNPTLGVH EADLLKTSGT LISFIYPAQN PELLNKLSQR KTTVLAMDQV
181 PRVTIAQGYD ALSSMANIAG YKAVVLAANH FGRFFTGQIT AAGKVPPAKI LIVGGGVAGL
241 ASAGAAKSMG AIVRGFDTRA AALEQFKSLG AEPLEVDLKE SGEGQGGYAK EMSKEFIEAE
301 MKLFAQQCKE VDILISTALI PGKKAPVLFN KEMIESMKEG SVVVDLAAEA GGNFETTKPG
361 ELYIHKGITH IGYTDLPSRM ATQASTLYSN NITKLLKAIS PDKDNFYFDV KDDFDFGTMG
421 HVIRGTVVMK DGKVIFPAPT PKNIPQGAPV KQKTVAELEA EKAATITPFR KTMSTASAYT
481 AGLTGILGLG IAAPNLAFSQ MVTTFGLAGI VGYHTVWGVT PALHSPLMSV TNAISGLTAV
541 GGLALMGGHL YPSTTSQGLA ALAAFISSVN IAGGFLVTQR MLDMFKRPTD PPEYNYLYLL
601 PAGTFVGGYL AALYSGYNIE QIMYLGSGLC CVGALAGLST QGTARLGNAL GMIGVAGGLA
661 ATLGVLKPGP ELLAQMSGAM ALGGTIGLTI AKRIQISDLP QLVAAFHSLV GLAAVLTCIA
721 EYIIEYPHFA TDAAANLTKI VAYLGTYIGG VTFSGSLIAY GKLQGLLKSA PLLLPGRHLL
781 NAGLLAASVG GIIPFMVDPS FTTGITCLGS VSALSAVMGV TLTAAIGGAD MPVVITVLNS
841 YSGWALCAEG FLLNNNLLTI VGALIGSSGA ILSYIMCVAM NRSLANVILG GYGTTSTAGG
901 KPMEISGTHT EINLDNAIDM IREANSIIIT PGYGLCAAKA QYPIADLVKM LTEQGKKVRF
961 GIHPVAGRMP GQLNVLLAEA GVPYDIVLEM DEINHDFPDT DLVLVIGAND TVNSAAQEDP
1021 NSIIAGMPVL EVWKSKQVIV MKRSLGVGYA AVDNPIFYKP NTAMLLGDAK KTCDALQAKV
1081 RESYQKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NNT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 14
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 359 nTPM
Expression across tissuesHPA
Tissue
- tongue: 359 nTPM
- skeletal muscle: 224 nTPM
- heart muscle: 129 nTPM
- liver: 109 nTPM
- kidney: 53 nTPM
- parathyroid gland: 52 nTPM
Single-cell type
- cardiomyocytes: 795 nCPM
- myonuclei: 472 nCPM
- hepatocytes: 425 nCPM
- parietal cells: 308 nCPM
- choroid plexus epithelial cells: 278 nCPM
- distal convoluted tubule cells: 276 nCPM
Immune cell
- myeloid DC: 32 nTPM
- non-classical monocyte: 25 nTPM
- NK-cell: 23 nTPM
- intermediate monocyte: 23 nTPM
- T-reg: 22 nTPM
- total PBMC: 19 nTPM
Brain region
- choroid plexus: 91 nTPM
- cerebral cortex: 61 nTPM
- thalamus: 52 nTPM
- basal ganglia: 49 nTPM
- hippocampal formation: 48 nTPM
- white matter: 47 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NNT.
Disease | AllUniProt
Conditions NNT is implicated in, by any mechanism.
- Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency (GCCD4) MIM:614736
Disease | GeneticClinVar
29 pathogenic / likely-pathogenic of 326 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Glucocorticoid deficiency 4
- GLUCOCORTICOID DEFICIENCY 4 WITH MINERALOCORTICOID DEFICIENCY
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.31
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 2.08
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell redox homeostasis
- cellular oxidant detoxification
- intracellular oxygen homeostasis
- NADPH regeneration
- negative regulation of apoptotic process
- positive regulation of hydrogen peroxide catabolic process
- positive regulation of mitochondrial membrane potential
- proton transmembrane transport
- reactive oxygen species metabolic process
- response to vitamin
- tricarboxylic acid cycle
Molecular functions
- NAD binding
- NADP binding
- NAD(P)+ transhydrogenase (Si-specific) activity
- proton-translocating NAD(P)+ transhydrogenase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Alanine dehydrogenase/pyridine nucleotide transhydrogenase, NAD(H)-binding domain
- Alanine dehydrogenase/pyridine nucleotide transhydrogenase, N-terminal
- DHS-like NAD/FAD-binding domain superfamily
- NAD(P)-binding domain superfamily
- Alanine dehydrogenase/PNT, N-terminal domain
- Alanine dehydrogenase/NAD(P) transhydrogenase, conserved site-1
- Alanine dehydrogenase/pyridine nucleotide transhydrogenase, conserved site-2
- NAD(P) transhydrogenase, alpha subunit, C-terminal
- NAD(P) transhydrogenase, alpha subunit
- NADP transhydrogenase beta-like domain
- Alanine dehydrogenase/PNT, C-terminal domain
- NAD(P) transhydrogenase beta subunit
- 4TM region of pyridine nucleotide transhydrogenase, mitoch
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NNT as an antibody target. Whether an autoantibody or antibody against NNT could matter depends on whether native NNT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NNT is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NNT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...